11-12 EST, April 27, 2022
*Some of the panelists responses have been edited*
Generics are Coming to Market for HIV and Humira. How does an Employer Ensure they Maximize this Opportunity? In the next few years there are some big drugs that will have biosimilar or generic alternatives that are complete therapeutic alternatives coming to market, but employers may not appreciate their impact on their finances due to market influencers. .
During this session, you will learn:
Cost Plus Drugs